Department of Medicine

November 17, 2016

V Foundation grants bolster cancer initiatives

Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC.

By VUMC News and Communications
November 10, 2016

Grants enhance Tuberculosis Center’s global research efforts

Since July, investigators in the Vanderbilt Tuberculosis Center have been awarded research grants totaling $5 million.

By Paul Govern
November 10, 2016

Program seeks to optimize appropriate use of antibiotics

Relying on a core team of physicians and pharmacists, the Vanderbilt Antimicrobial Stewardship Program (VASP) is seeking to ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC).

By Paul Govern
November 3, 2016

Study details rare heart risk of certain cancer therapies

By VUMC News and Communications
October 27, 2016

Iadecola set for Oates Lectureship in Clinical Pharmacology

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.

By Bill Snyder
Buckwheat seeds on wooden spoon in closeup
October 20, 2016

Study finds natural compound extends lifespan of worms

A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered.

By Leigh MacMillan
October 20, 2016

Forum celebrates VUMC translational research expertise

Vanderbilt University Medical Center’s vibrant culture of clinical and translational research was celebrated at an annual forum last week, and two physician-scientist leaders were honored with awards.
By Leigh MacMillan
October 20, 2016

VICC trial putting lung cancer therapy to the test

Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.
By VUMC News and Communications
October 13, 2016

EGF receptor found to regulate macrophage inflammation in gut

Researchers at Vanderbilt University School of Medicine have uncovered a link between epidermal growth factor receptor (EGFR) signaling and the inflammatory response to bacterial infection in the gastrointestinal tract.
By Bill Snyder
October 6, 2016

Vanderbilt scientists to lead chronic disease research initiative in Vietnam

Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.
By VUMC News and Communications
September 29, 2016

Childhood health influences focus of new NIH initiative

The National Institutes of Health (NIH) recently announced it will provide $157 million in awards to launch a multi-center, seven-year initiative that will investigate how exposure to environmental factors in early development — from conception through early childhood — influences the health of children and adolescents.
By Kathy Whitney
September 29, 2016

American College of Critical Care Medicine honors Bernard

Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017.
By Bill Snyder
September 29, 2016

BMI genotype and breast cancer risk

For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults.
By Paul Govern
1 … 92 93 94 95 96 … 125